ES2129749T3 - Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo. - Google Patents

Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.

Info

Publication number
ES2129749T3
ES2129749T3 ES95202092T ES95202092T ES2129749T3 ES 2129749 T3 ES2129749 T3 ES 2129749T3 ES 95202092 T ES95202092 T ES 95202092T ES 95202092 T ES95202092 T ES 95202092T ES 2129749 T3 ES2129749 T3 ES 2129749T3
Authority
ES
Spain
Prior art keywords
vector
production
hirudin
microorganism
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95202092T
Other languages
English (en)
Inventor
Satoru Misawa
Yoshifumi Inoue
Hitoshi Matsuda
Hideyuki Furuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2303096A external-priority patent/JPH07119237B2/ja
Priority claimed from JP4127191A external-priority patent/JP3226289B2/ja
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Application granted granted Critical
Publication of ES2129749T3 publication Critical patent/ES2129749T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN VECTOR DE SECRECION PARA LA PRODUCCION DE PROTEIA EXTRAÑA, EN PARTICULAR HIRUDIN HV1, HIRUDIN HV3 Y ANALOGO DE HIRUDIN HV1C3, QUE CONSTA DE UN ORIGEN DE REPLICACION (ORI) DE UN PUC PLASMICO, UN PROMOTOR DE TAC O TRP, UNA SECUENCIA DE DNA QUE CODIFICA PEPTIDOS DE SEÑAL, UNA SECUENCIA DE DNA QUE CODIFICA UNA PROTEINA EXTRAÑA, ENLAZADOS TODOS DE MANERA OPERABLE. TAMBIEN SE PROPORCIONA UN METODO PARA PRODUCIR DICHOS HIRUDINES Y ANALOGOS DE HIRUDIN, EMPLEANDO LOS VECTORES DE SECRECION Y MICROORGANISMOS TRANSFORMADOS COMO E. COLI.
ES95202092T 1990-11-08 1991-11-08 Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo. Expired - Lifetime ES2129749T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2303096A JPH07119237B2 (ja) 1990-11-08 1990-11-08 ヒルジン変異体，その製造法及び抗凝血剤
JP4127191A JP3226289B2 (ja) 1991-02-13 1991-02-13 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法

Publications (1)

Publication Number Publication Date
ES2129749T3 true ES2129749T3 (es) 1999-06-16

Family

ID=26380836

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91919149T Expired - Lifetime ES2093717T3 (es) 1990-11-08 1991-11-08 Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.
ES95202092T Expired - Lifetime ES2129749T3 (es) 1990-11-08 1991-11-08 Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES91919149T Expired - Lifetime ES2093717T3 (es) 1990-11-08 1991-11-08 Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.

Country Status (12)

Country Link
US (2) US5516656A (es)
EP (2) EP0511393B1 (es)
AT (2) ATE176500T1 (es)
AU (2) AU648124B2 (es)
CA (2) CA2072375C (es)
DE (2) DE69130872T2 (es)
DK (2) DK0511393T3 (es)
ES (2) ES2093717T3 (es)
FI (1) FI107928B (es)
GR (2) GR3021410T3 (es)
NO (2) NO303735B1 (es)
WO (1) WO1992008736A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
CA2205356A1 (en) * 1994-11-21 1996-05-30 Peter Edward Urwin Modified proteinase inhibitors
DE19944870A1 (de) * 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
DE10108211A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
CA2496990A1 (en) * 2002-08-23 2004-03-04 E.I. Du Pont De Nemours And Company Utilization of starch products for biological production by fermentation
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
EP1903115B1 (de) * 2006-09-22 2011-03-09 Wacker Chemie AG Verfahren zur fermentativen Herstellung von Antikörpern
CN101372512B (zh) * 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
WO2010054503A1 (zh) * 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 抗凝血多肽及其应用
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
JP2518862B2 (ja) * 1987-08-31 1996-07-31 株式会社蛋白工学研究所 新規プラスミドベクタ―
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
AU614121B2 (en) 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
JPH0648988B2 (ja) 1988-07-26 1994-06-29 工業技術院長 トロンビン阻害物質の製造法
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH0292288A (ja) * 1988-09-30 1990-04-03 Japan Tobacco Inc アクアライシンｉ前駆体をコードする遺伝子、それを含む発現ベクター、該発現ベクターを含む大腸菌及びそれを用いたアクアライシンｉの製造方法
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
IE902877A1 (en) * 1989-08-10 1991-02-27 Japan Energy Corp Expression vector for hirudin, hirudin fusion protein,¹transformed microorganism and method for production of¹hirudin
JPH03164184A (ja) 1989-08-10 1991-07-16 Nippon Mining Co Ltd ヒルジン発現ベクター、ヒルジン融合蛋白、形質転換微生物及びヒルジンの製造法
JPH0376579A (ja) 1989-08-18 1991-04-02 Nippon Mining Co Ltd ヒト‐アンジオジェニン発現ベクター及びヒト‐アンジオジェニンの製造方法
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins

Also Published As

Publication number Publication date
AU648124B2 (en) 1994-04-14
AU673870B2 (en) 1996-11-28
DE69121192T2 (de) 1997-02-20
WO1992008736A1 (en) 1992-05-29
FI922963A0 (fi) 1992-06-26
EP0687731A1 (en) 1995-12-20
GR3021410T3 (en) 1997-01-31
GR3029824T3 (en) 1999-06-30
AU5470194A (en) 1994-03-24
NO982207D0 (no) 1998-05-14
NO922671D0 (no) 1992-07-07
EP0687731B1 (en) 1999-02-03
DK0511393T3 (da) 1996-12-09
CA2072375C (en) 2000-01-11
ATE140929T1 (de) 1996-08-15
DK0687731T3 (da) 1999-09-20
EP0511393A1 (en) 1992-11-04
AU8846691A (en) 1992-06-11
ATE176500T1 (de) 1999-02-15
NO982207L (no) 1992-09-07
CA2072375A1 (en) 1992-05-09
DE69121192D1 (de) 1996-09-05
FI922963L (fi) 1992-06-26
NO303735B1 (no) 1998-08-24
DE69130872D1 (de) 1999-03-18
US5516656A (en) 1996-05-14
CA2255396A1 (en) 1992-05-09
US5573929A (en) 1996-11-12
EP0511393B1 (en) 1996-07-31
ES2093717T3 (es) 1997-01-01
NO922671L (no) 1992-09-07
FI107928B (fi) 2001-10-31
DE69130872T2 (de) 1999-08-26
EP0511393A4 (en) 1993-08-11

Similar Documents

Publication Publication Date Title
ES2129749T3 (es) Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.
AU1672388A (en) Expression of human proapolipoprotein a-i
MX9307855A (es) Sistema de expresion para producir apolipotroteina ai-m.
ES8801851A1 (es) Un metodo para producir bacterianamente un polipeptido heteralogo que tiene actividad somatotropinica.
ES2061632T5 (es) Kluyveromyces como celula hospedante.
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
AU5698686A (en) Promotors of filamentous fungi and use thereof
GR3023593T3 (en) Protein structure of the plant toxin gelonin
SV1994000029A (es) Toxina contra arañas insecticidamente eficaz ol 4797
DK0529373T3 (da) Disulfider, fremgangsmåde til fremstilling og anvendelse deraf
DK0506040T3 (da) Mutant AOX2 promotor, mikroorganismer indeholdende denne, fremgangsmåde til fremstilling deraf og produktion af heterologt
KR900702010A (ko) 루시페라아제, 그것을 코우드 하는 유전자 및 루시페라아제의 생산방법
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido
AU1438992A (en) Water extraction components produced by adhesive bonds, process for their manufacture and their use
ES2079128T3 (es) Procedimiento para evitar el pardeamiento de un producto alimentario.
ES2055066T3 (es) Anticuerpos monoclonales que reconocen el extremo n del gamma polipeptido natriuretico atrial, hibridomas que los producen y su preparacion y aplicacion.
DE3574731D1 (de) Ein menschlicher t-zellwachstumsfaktor.
ES2076318T3 (es) Control de la acumulacion de vectores de expresion aberrantes durante procedimientos de fermentacion.
TW197410B (es)
GR1001635B (el) Μέ?οδος παρασκευής 3-[2-(διμε?υλαμινο)-αι?υλο]-ν-με?υλο-1η-ινδόλης-5-με?ανοσουλφοναμίδης.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 687731

Country of ref document: ES